SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma

NCT01482442 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

496

Enrollment

OTHER

Sponsor class

Conditions

Liver Carcinoma

Interventions

DRUG: sorafenib
DRUG: SIR-Sphere

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]